Investors Flee Spectranetics as Fed Investigates

In an announcement that sent investors clamoring for cover, the U.S. District Court of Colorado served Spectranetics with a search warrant.

It seems that both FDA and U.S. Immigration and Customs Enforcement officials suspect the maker of excimer lasers hasn’t been playing by the rules. The search warrant requested information and correspondence related to:

• The promotion, use, testing, marketing and sales related to the company’s in-stent restenosis treatment.
• The promotion, use, testing, experimentation, delivery, marketing and sales of catheter guidewires and balloon catheters.
• Two post-market studies completed during the period from 2002 to 2005 and payments to medical personnel in connection with those studies.
• Compensation packages for certain employees.

NASDAQ halted trading of Spectranetics on the news. When trading resumed, shares dropped over $4. Spectranetics is cooperating with authorities.

Previously: Spectranetics Buys Kensey Nash Endovascular Unit



No Responses to “Investors Flee Spectranetics as Fed Investigates”

1. » Spectranetics Halts SALVAGE Trial After FDA Voices Concern | OneMedPlace » Archive says:

   September 16, 2008 at 8:37 am

   [...] a break. The Colorado Springs-based manufacturers of excimer lasers saw its share price plummet after the Fed issued search warrants so that it can investigate the company’s sales and marketing …, among other [...]
2. » Spectranetics Releases 12-Month CELLO Study Data | OneMedPlace » Archive says:

   January 22, 2009 at 9:13 am

   [...] Previously: Investors Flee Spectranetics as Fed Investigates [...]